European Union in talks to secure Sanofi deal for coronavirus vaccine
published 01.08.2020 12:32
"It is envisaged that, once a vaccine has proven to be safe and effective against Covid-19, the Commission would have a contractual framework in place for the purchase of 300 million doses, on behalf of all EU member states."
"The envisaged contract with would provide for an option for all EU Member States to purchase the vaccine," the Commission said in a statement.
The Commission said the aim of the talks with was to clinch an advance purchase deal.
SA and GlaxoSmithKline Plc on Friday said they were in advanced discussions to supply up to 300 million doses of an experimental Covid-19 vaccine for the 27-country Armed with an emergency fund of more than 2 billion euros (£1.80 billion), the European Commission wants to strike deals with up to six drugmakers for their vaccines for their 450 million citizens against the that has killed 674,000 people worldwide.
A Commission spokesman said he could not comment on when a deal would be announced and the possible price for the vaccine, calling it a quite promising step towards an eventual agreement.